0001192482-21-000241.txt : 20210310 0001192482-21-000241.hdr.sgml : 20210310 20210310202433 ACCESSION NUMBER: 0001192482-21-000241 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210308 FILED AS OF DATE: 20210310 DATE AS OF CHANGE: 20210310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Casten Richard S CENTRAL INDEX KEY: 0001850307 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39101 FILM NUMBER: 21731482 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Baudax Bio, Inc. CENTRAL INDEX KEY: 0001780097 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 474639500 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-395-2470 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Recro Enterprises, Inc. DATE OF NAME CHANGE: 20190618 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2021-03-08 0001780097 Baudax Bio, Inc. BXRX 0001850307 Casten Richard S C/O BAUDAX BIO, INC. 490 LAPP ROAD MALVERN PA 19355 0 1 0 0 Chief Financial Officer Common Stock 2021-03-08 4 A 0 15000 0 A 15000 D Common Stock 2021-03-08 4 A 0 85000 0 A 100000 D Stock Option (right to buy) 1.21 2021-03-08 4 A 0 15000 0 A 2031-03-08 Common Stock 15000 15000 D Stock Option (right to buy) 1.21 2021-03-08 4 A 0 255000 0 A 2031-03-08 Common Stock 255000 255000 D These restricted stock units will vest in full on December 31, 2021, subject to continued service with the Company. These restricted stock units will vest in four equal annual installments beginning on March 8, 2022, subject to continued service with the Company. The stock option will vest in full on December 31, 2021, subject to continued service with the Company. The stock option vests in equal monthly installments over 48 months, beginning on April 8, 2021, subject to continued service to the Company. /s/ Richard S. Casten 2021-03-10